Search

Admedus taps investors for $18m

Biotech firm Admedus has tapped investors for $18.3 million to fund ongoing development of its medical technologies.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

BNIQ sponsored byLedge Finance

Admedus (AHZ)

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 31/12/18

1 year TSR5 year TSR
thVonex
55thI Synergy Group52%
274thKatana Capital-3%3%
506thRefresh Group-37%9%
798thAdmedus-79%-47%
716 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

28/06/18
$50k Issued
28/06/18
$50k Issued
28/06/18
$100k Issued
Total value as at the date of the transaction
Source: Morningstar

Revenue

84th↓Admedus$11.7m
87th↑I Synergy Group$10.8m
88th↑Katana Capital$10.3m
90th↓Refresh Group$8.8m
91st-Vonex$8.5m
237 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer